🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Hemophilia A With Inhibitor

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B NCT05611801Phase 363 sites📍 Salt Lake City📍 Mendoza📍 Parkville Pfizer · Tests: marstacimab PCC Treatment for Hemophilia Patients With Inhibitor（2022PCC-A） NCT07406139Phase 41 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: PCC Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors NCT05145127Phase 378 sites📍 Iowa City📍 New Hyde Park📍 Philadelphia Pfizer · Tests: PF-06741086 Treatment of Hemophilia A Patients With FVIII Inhibitors NCT04023019n/a2 sites📍 Atlanta📍 Mörfelden-Walldorf Emory University · Tests: Nuwiq, Octanate, Wilate, Emicizumab, Recombinant factor VIIa (rFVIIa) A Study on the Bone-health Effectiveness of Applying Recombinant Factor VIII Fc (rFVIIIFc) to Patients With Hemophilia A (Prototype A) NCT05981274n/a1 site📍 Taipei Tri-Service General Hospital (TSGH) · Tests: serum biomarker. Multidimensional Assessment of Chronic Pain in Severe Haemophilia A NCT07096349n/a1 site📍 Oviedo Investigación en Hemofilia y Fisioterapia Assessing Different FVIII Doses and Frequencies in Immune Tolerance Induction (ITI) with ADVATE Among Hemophilia a Boys with Inhibitor (INITIATE Study) NCT06864975Phase 41 site📍 Beijing Runhui WU · Tests: Advate®, Advate®, Advate®, Advate®, Advate® Dynamics of the Anti-factor VIII Antibody Signature During Treatment With Emicizumab NCT05802836n/a1 site📍 Frankfurt am Main Christoph Königs · Tests: no interventions SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors NCT04647227Phase 421 sites📍 Phoenix📍 Little Rock📍 Los Angeles American Thrombosis and Hemostasis Network · Tests: coagulation factor VIIa [recombinant]-jncw ITI Using SCT800 Alone or Combining Daratumumab in Hemophilia A Adolescents and Adults With High Titer Inhibitor NCT05888870Phase 41 site📍 Tianjin Institute of Hematology & Blood Diseases Hospital, China · Tests: SCT800 and Daratumumab, SCT800
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy